This is the authors' abstract. We don't add key points for this paper.
mutation status. These results support further investigation of development strategies for U3-1402 in patients with HER3-expressing colorectal cancer.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Koganemaru et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: